Skip to content

Clinical study of homoeopathic treatment in the management of Prostate enlargement.

A clinical study of Individualized Homoeopathic treatment in the management of Benign Prostatic Hyperplasia using the International Prostate Symptom Score. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065820
Enrollment
30
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Individualized Homoeopathic medicine obtained after repertorization.: Potentized Homoeopathic medicine in the form of powder or pills. Route of Administration: Oral Selection of Potency

Sponsors

Sai Bhaskar D
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who fulfill the case definition. Patients aged 40 years and above will be included in the study. Only symptomatic patients will be taken into the study. Patients without any advanced systemic illnesses. Patients willing to participate in the study and willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: Patients with IPSS score of greater than 20 (severe BPH) requiring surgical intervention. Patients with Hematuria will not be taken into the study. Patients with Vesical Calculi (Urinary bladder stones). Patients under any other medications for BPH.

Design outcomes

Primary

MeasureTime frame
To ascertain the effectiveness of Individualized Homoeopathic medicines in cases of BPH and clinically assess the outcome by using IPSS, BII (BPH Impact Index) which is a Quality of Life index, every 15 days.Timepoint: The patient will be followed up every 15 days and his IPSS score and BII scores will be recorded every 15 days to assess the effect of the given treatment and the progress of the condition.

Secondary

MeasureTime frame
To assess the variation in Post-void Residual Volume (PVR volume) by USG pelvis before and after the treatment.Timepoint: Every patient will be under Homoeopathic treatment for 3 months and USG Pelvis will be recorded before and after the 3 months of treatment to assess the variation in the PVR volume.

Countries

India

Contacts

Public ContactSai Bhaskar D

Bharati Vidyapeeth (Deemed to be University) Homoeopathic Medical College and Homoeopathic Hospital

sameer.nadgauda@bharatividyapeeth.edu9970153078

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026